Creative Proteomics provides a high-quality and high-sensitivity analysis to detect and quantify HCPs by mass spectrometry (MS), in accordance with relevant guidelines (ICH Q6B, PharmEu and USP). The HCP coverage of generic or process-specific Enzyme Linked Immunosorbent Assay (ELISA) polyclonal antibodies can also be validated. Our professional scientists and analysts will deploy optimal approaches to fully detect, characterize, and quantify HCPs in the biopharmaceutical products, and meet requirements of each stage of drug discovery.
Doug Monsour
Hb88
Khanit
Garet
Brilla Max Llc
Servpro Of Cedar Mill/oak Hills
Brilla Max Llc
Kirkland Weber
Mckinnon Willard
Net88